Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Obel

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
HIV Medicine|September 17, 2004
Resistance profiles and adherence at primary virological failure in three different highly active antiretroviral therapy regimens: analysis of failure rates in a randomized studyB T Røge, T S Barfod, O Kirk, et al.
HIV Medicine|August 24, 2010
HIV and risk of venous thromboembolism: a Danish nationwide population-based cohort studyL D Rasmussen, M Dybdal, J Gerstoft, et al.
HIV Medicine|June 11, 2015
Incidence of cervical dysplasia and cervical cancer in women living with HIV in Denmark: comparison with the general populationK Thorsteinsson, S Ladelund, S Jensen-Fangel, et al.
Leukemia|November 1, 1995
Improved vaccination response during ranitidine treatment, and increased plasma histamine concentrations, in patients with B cell chronic lymphocytic leukemiaJ Jurlander, P de Nully Brown, P S Skov, et al.
HIV Medicine|September 15, 2015
Soluble urokinase plasminogen activator receptor (suPAR) is a novel, independent predictive marker of myocardial infarction in HIV-1-infected patients: a nested case-control studyL J H Rasmussen, A Knudsen, T L Katzenstein, et al.
Journal of Viral Hepatitis|June 3, 2009
Predictors of antiviral treatment initiation in hepatitis C virus-infected patients: a Danish cohort studyN Hansen, N Obel, P B Christensen, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 16, 2013
Health care index score and risk of death following tuberculosis diagnosis in HIV-positive patientsD N Podlekareva, D Grint, F A Post, et al.
HIV Medicine|September 15, 2016
Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patientsV Bouteloup, C Sabin, A Mocroft, et al.
HIV Medicine|September 15, 2016
Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in EuropeA Judd, R Lodwick, A Noguera-Julian, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2013
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy eraA Mocroft, H J Furrer, J M Miro, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
HIV Medicine|September 17, 2004
Resistance profiles and adherence at primary virological failure in three different highly active antiretroviral therapy regimens: analysis of failure rates in a randomized studyB T Røge, T S Barfod, O Kirk, et al.
HIV Medicine|August 24, 2010
HIV and risk of venous thromboembolism: a Danish nationwide population-based cohort studyL D Rasmussen, M Dybdal, J Gerstoft, et al.
HIV Medicine|June 11, 2015
Incidence of cervical dysplasia and cervical cancer in women living with HIV in Denmark: comparison with the general populationK Thorsteinsson, S Ladelund, S Jensen-Fangel, et al.
Leukemia|November 1, 1995
Improved vaccination response during ranitidine treatment, and increased plasma histamine concentrations, in patients with B cell chronic lymphocytic leukemiaJ Jurlander, P de Nully Brown, P S Skov, et al.
HIV Medicine|September 15, 2015
Soluble urokinase plasminogen activator receptor (suPAR) is a novel, independent predictive marker of myocardial infarction in HIV-1-infected patients: a nested case-control studyL J H Rasmussen, A Knudsen, T L Katzenstein, et al.
Journal of Viral Hepatitis|June 3, 2009
Predictors of antiviral treatment initiation in hepatitis C virus-infected patients: a Danish cohort studyN Hansen, N Obel, P B Christensen, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 16, 2013
Health care index score and risk of death following tuberculosis diagnosis in HIV-positive patientsD N Podlekareva, D Grint, F A Post, et al.
HIV Medicine|September 15, 2016
Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patientsV Bouteloup, C Sabin, A Mocroft, et al.
HIV Medicine|September 15, 2016
Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in EuropeA Judd, R Lodwick, A Noguera-Julian, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2013
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy eraA Mocroft, H J Furrer, J M Miro, et al.
Pageof 11